Groesbeck Investment Management’s Sanofi SNY Stock Holding History

Groesbeck Investment Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,140	Closed	-$451K	–	85
2025 Q1	$451K	Hold	8,140	–	–	0.63%	51
2024 Q4	$393K	Buy	+8,140	New	+$414K	0.51%	61
2024 Q2	–	Sell	-8,140	Closed	-$396K	–	94
2024 Q1	$396K	Buy	+8,140	New	+$397K	0.42%	71
2022 Q2	–	Sell	-8,140	Closed	-$418K	–	104
2022 Q1	$418K	Buy	+8,140	New	+$420K	0.47%	74
2021 Q4	–	Sell	-8,140	Closed	-$392K	–	106
2021 Q3	$392K	Buy	+8,140	New	+$414K	0.45%	81
2016 Q4	–	Sell	-8,140	Closed	-$311K	–	102
2016 Q3	$311K	Buy	+8,140	New	+$327K	0.23%	90

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Groesbeck Investment Management's SNY Position: Q2 2025 in Review

Groesbeck Investment Management sold out of Sanofi (SNY) in Q2 2025, closing a stake of 8,140 shares — an estimated $451K sold.

Groesbeck Investment Management first reported a position in SNY in Q3 2016 and held it in 6 quarters. The position peaked at $451K in Q1 2025. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

Groesbeck Investment Management reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
Groesbeck Investment Management sold 8,140 Sanofi shares in Q2 2025, an estimated $451K.
Groesbeck Investment Management first reported a position in Sanofi in Q3 2016 and held it in 6 quarters.
Groesbeck Investment Management's Sanofi position peaked at $451K in Q1 2025.
730 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Groesbeck Investment Management's 13F filing for Q2 2025, filed 23 Oct 2025.